Lastly, simultaneous inhibition of BET proteins and the chemokine receptor CXCR4 augmented MYC reduction in DLBCL cells, thus leading to a reduced tumor burden in transplanted xenografts [235]. Here, MYC is linked to diffuse large B-cell lymphoma.